Clinical trials
catalyst calendar across sponsors →Studies where ATI is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
2 observational
Held by 23 tracked-famous managers (Qube Research & Technologies Ltd, AQR CAPITAL MANAGEMENT LLC, JANE STREET GROUP, LLC, Point72 Asset Management, L.P., VIKING GLOBAL INVESTORS LP, +18 more) · FINRA short interest 2.5 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 9 sells · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| ATI Evidence-based Guide Investigating Medical and Preventative ServicesNCT04050319observationalNumerical Rating Scale (NRS) | — | Active, not recruiting | Diagnostic test: Screening and diagnosis if injured | Sport Medicine | 550,000 | 2029-04-23 | in 978 d | 2026-05-04 |
| ATI Evidence-based Guide Investigating Clinical ServicesNCT02285868observationalChange in functional status | — | Active, not recruiting | — | Primary Body Region (Arranged Most Common to Least), Lumbar/SI, Knee, Shoulder, Cervical/Thoracic, Foot/Ankle, Hip, Elbow, Neurological, Vestibular, Pelvic Floor, TMJ, Fibromyalgia, Headaches, Lymphedema | 4,000,000 | 2029-02-24 | in 920 d | 2026-03-05 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19